CompletedNCT00159965
Sertraline for depression and anxiety in people with nonepileptic seizures
About this title
Read the official source — NCT00159965Medication studyAges 18–95United StatesPTSD
Understand this study
Who was this study for?
Listed age limits: 18 years to 95 years.
- Listed locations
- ProvidenceSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateDecember 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 38
- Sponsor
- Rhode Island Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 95 Years
- Official registry ID
- NCT00159965
- Official title
Show the full official title
Treatment for Psychogenic Nonepileptic Seizures: A Pilot, 12 Week, Prospective, Randomized, Placebo-controlled, Double-blind, Clinical Trial of Sertraline in the Treatment of Comorbid Psychiatric Disorders in NES
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Providence
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Rhode Island Hospital, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including sertraline and placebo.
Who was this study for?
Listed age limits: 18 years to 95 years.
